Newsroom

Dear Healthcare Professional

Title

20-Vgu-Metformin

Additional Risk Minimization Measure Enbrel

DHCPL

wdt_ID wdt_created_by wdt_created_at wdt_last_edited_by wdt_last_edited_at DATE TITLE
1 prmis 12/09/2024 10:54 PM Kwabena Sarfo 08/10/2024 02:52 PM 03/01/2010 BOXED WARNING - EXJADE (DEFERASIROX) - DHCPL
2 prmis 12/09/2024 10:54 PM SYLVESTER 13/09/2024 06:00 PM 05/08/2012 ASSOCIATION OF IBANDRONIC ACID AND ANAPHYLAXIS (ANAPHYLACTIC REACTION, ANAPHYLACTIC SHOCK) - DHCPL
3 prmis 12/09/2024 10:54 PM prmis 12/09/2024 10:54 PM 08/02/2013 ORAL KETOCONAZOLE AND THE RISK OF SEVERE LIVER INJURY, ADRENAL GLAND PROBLEMS AND HARMFUL DRUG INTERACTIONS - DHCPL
4 prmis 12/09/2024 10:54 PM SYLVESTER 13/09/2024 06:05 PM 03/01/2017 RARE BUT SERIOUS ALLERGIC REACTIONS WITH THE SKIN ANTISEPTIC CHLORHEXIDINE GLUCONATE - DHCPL
5 prmis 12/09/2024 10:54 PM SYLVESTER 13/09/2024 06:07 PM 07/05/2017 UPDATE ON SAFETY OF PIOGLITAZONE - DHCPL
6 prmis 12/09/2024 10:54 PM SYLVESTER 13/09/2024 06:08 PM 11/02/2018 SUSPENSION OF MARKETING AUTHORIZATION FOR ORAL KETOCONAZOLE PRODUCTS - DHCPL
7 prmis 12/09/2024 10:54 PM SYLVESTER 13/09/2024 11:42 PM 12/03/2018 FOLLOW UP-SUSPENSION OF MARKET AUTHORIZATION OF CODEINE CONTAINING COUGH SYRUPS - DHCPL
8 prmis 12/09/2024 10:54 PM SYLVESTER 13/09/2024 06:16 PM 12/06/2018 RECALL OF AMLODIPIN-VALSATAN COMBINATION TABLETS - DHCPL
9 prmis 12/09/2024 10:54 PM SYLVESTER 13/09/2024 11:50 PM 23/01/2019 RESTRICTIONS TO PREVENT THE USE OF VALPROATE MEDICINES IN WOMEN AND GIRLS OF CHILDBEARING POTENTIAL - DHCPL
10 prmis 12/09/2024 10:54 PM SYLVESTER 13/09/2024 11:56 PM 27/02/2019 RESTRICTIONS ON THE USE OF FLUOROQUINOLONE DUE TO INCREASED RISK OF RUPTURES OR TEARS IN THE AORTA BLOOD VESSEL